How much is the current price of a box of Crizotinib in RMB?
Crizotinib (Crizotinib), as a targeted therapy drug, has been officially launched in China and has been included in the medical insurance catalog. This means that patients can enjoy certain medical insurance reimbursement when purchasing this drug, reducing the burden of medication. Crizotinib currently has two main specifications in China: 250mg 60 tablets and 200mg 60 tablets. The market price of each box is usually more than 10,000 yuan. Specific medical insurance reimbursement prices will vary from region to region, and patients are advised to consult their local hospital pharmacy for accurate information.
In the domestic market, the price of crizotinib is relatively stable, but it is still a relatively high-priced anti-cancer targeted drug. Due to the high R&D and production costs of drugs and market demand, it is normal for prices to remain above RMB 10,000. During treatment with crizotinib, patients should reasonably select dosage and specifications based on the guidance of their doctor to ensure the therapeutic effect while minimizing medical cost control.
The price of the original crizotinib drug in overseas markets is also not low. Due to exchange rates and market differences, the price of each box may exceed RMB 10,000. In contrast, generic versions of crizotinib have appeared in some overseas regions, especially Laos and other places. The active ingredients of these generic drugs are basically the same as those of the original drugs, but the prices are more affordable. For example, the generic drug of 250 mg 60 tablets produced by Lucius Pharmaceuticals in Laos is priced at about more than 1,000 yuan, which significantly reduces the cost of medication for patients.
Overall, crizotinib is a high-value anti-cancer drug at home and abroad, and it is expensive. When choosing a drug purchase channel, patients can comprehensively consider medical insurance policies, drug specifications, and financial affordability. In China, due to medical insurance support, patients' financial pressure has been alleviated; and for some patients with limited financial conditions or who need long-term medication, choosing overseas generic drugs is also a feasible alternative.
Reference materials:https://go.drugbank.com/drugs/DB08865
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)